FDA Approved: ALPRAZOLAM — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Alprazolam by Par Health USA, LLC. This action likely updates labeling or expands the indication for alprazolam.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Panic Disorder

Drugs mentioned

• Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)